Inventaire - your friends and communities are your best library

Drug-drug interaction through molecular structure similarity analysis.

Author

Eugenio Uriarte

Lourdes Santana

Raúl Rabadán

1974 -

published in: Journal of the American Medical Informatics Association

date of publication: 2012-05-30

main subject: geometria molecular, interacció farmacològica

Bibliographic databases:

Cites articles 30

Date

Title

Authors

1995-07-01

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group
1995-10-01

The incident reporting system does not detect adverse drug events: a problem for quality improvement.
1997-01-01

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group
1997-08-01

Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units
1997-01-01

Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
2002-11-01

Reoptimization of MDL keys for use in drug discovery
2002-09-12

Do structurally similar molecules have similar biological activity?
2002-06-12

Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study

,
2002-03-01

The role of quantitative structure--activity relationships (QSAR) in biomolecular discovery
2002-02-01

Cerivastatin and reports of fatal rhabdomyolysis
2002-01-01

Adverse drug reactions as a cause for admissions to a department of internal medicine

,
2003-07-01

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
2006-11-01

Novel 2D fingerprints for ligand-based virtual screening
2006-02-01

Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action

,
2007-02

Relating protein pharmacology by ligand chemistry

,
2008-07-01

Exploiting QSAR models in lead optimization
2008-03-22

A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists
2008-03-13

Quantifying the relationships among drug classes

, , , ,
2008-01-01

Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery

,
2008-01-01

Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors
2009-02-01

Comparison of molecular fingerprint methods on the basis of biological profile data

,
2009-05-06

Predicting drug-drug interactions: an FDA perspective
2009-03-04

Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study

, ,
2010-10-28

Mining multi-item drug adverse effect associations in spontaneous reporting systems
2010-03-01

Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptor
2011-09-21

Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis

,
2011-06-14

A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports

,
2011-05-25

Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels

, ,
2011-05-19

Delineation of the molecular mechanisms of nucleoside recognition by cytidine deaminase through virtual screening

,
2011-02-26

Outcomes of emergency department patients presenting with adverse drug events.

Article -

Welcome to inventaire

The library of your friends and communities

Learn more